insulin antibody
111 Results
Ricerca avanzata
Visualizzare
-
-
Metabolism & Endocrinology Multiplex Assays Using Luminex® Technology | Life Science Research | Merck
Metabolism and endocrinology multiplex assays assist in the study of obesity, diabetes and associated conditions under the umbrella of metabolic syndrome. -
Cardiac Antibodies | Merck
Cardiovascular disease (CVD) is the leading cause of death worldwide. In 2012 an estimated 17.5 million people died of CVDs, representing 31% of total global deaths. Heart failure is the leading cause of hospitalization with more than 1 million cases annually in Europe and North America. -
Press Release: Merck Announces Exclusive Agreement with Julphar Diabetes to Offer Non-animal Origin, Recombinant Human Insulin as Cell Culture Media Supplement
Merck, today announced an exclusive agreement to sell recombinant human insulin manufactured by the United Arab Emirates-based pharmaceutical production company Julphar Diabetes. -
RNA-Binding Proteins | Life Science Research | Merck
RNA-binding proteins (RBPs) play a key role in post-transcriptional regulation of gene expression by binding to RNA along various points and at various times. -
TFA | Life Science Research | Merck
Transcription or posttranscriptional regulation (TFA) gene change affects the level or localization of protein expression. Characterization of the regulatory machinery is essential for understanding and potentially modulating biological responses encoded in genomic (and epigenomic) information. -
Neurodegenerative Diseases | Life Science Research | Merck
Neurodegenerative diseases are characterized by deterioration of neurons or their myelin sheath, disrupting transmission of sensory information, movement control, and more.